Chemotherapy- induced Peripheral Neuropathy: Assessment strategies, treatment and risk factors - 14/TPG/1-05

Project Member(s): Haas, M.

Funding or Partner Organisation: Cancer Institute NSW (Cancer Institute NSW- Translational Program Grants (TPG))

Start year: 2015

Summary: Nerve damage is a major side effect following chemotherapy treatment (chemotherapy- induced peripheral neuropathy; CIPN) that significantly affects quality of life in cancer survivors. There are currently no tools to measure its impact and no prevention or treatment. The major goals of this Translational Research Program are to comprehensively investigate the impact of CIPN in Australia, identify the best tools to measure CIPN and design interventions to treat and prevent CIPN. The Program will establish a clinical trials network to develop and trial interventions identified through translational research pathways and implement evidence-based guidelines for CIPN assessment and management.

FOR Codes: Health not elsewhere classified, Chemotherapy, Other Medical and Health Sciences, Other biomedical and clinical sciences, Determinants of health, Other health not elsewhere classified

Acknowledgement of Country

UTS acknowledges the Gadigal people of the Eora Nation, the Boorooberongal people of the Dharug Nation, the Bidiagal people and the Gamaygal people, upon whose ancestral lands our university stands. We would also like to pay respect to the Elders both past and present, acknowledging them as the traditional custodians of knowledge for these lands.